1-5 of 5
Christoph W.M. Reuter
Close
Sort by
Journal Articles

Modulation of Anthracycline-Induced Cytotoxicity by Targeting the Prenylated Prenylome in Myeloid Leukemia Cells

Michael A Morgan, PhD, Fredrick O Onono, Peter H Spielmann, Thangaiah Subramanian, Michaela Scherr, Letizia Venturinin, Iris Dallmann, Arnold Ganser, MD, Christoph W.M. Reuter
Journal: Blood
Blood (2011) 118 (21): 1418.
https://doi.org/10.1182/blood.V118.21.1418.1418
Published: 2011
Journal Articles

Potentiation of Topoisomerase II Inhibitor-Mediated Myeloid Leukemia Cell Kill by Farnesyltransferase Inhibitor L-744,832.

Fredrick O. Onono, MSc, Michael A. Morgan, PhD, Jeanny Wegner, MD, Arnold Ganser, MD/PhD, Christoph W.M. Reuter, MD/PhD
Journal: Blood
Blood (2007) 110 (11): 3479.
https://doi.org/10.1182/blood.V110.11.3479.3479
Published: 2007
Journal Articles

Characterization of a Novel R-RAS Mutation Cloned from Primary AML Cells.

Christoph W.M. Reuter, MD, PhD, Erdem Aydilek, MD, Fredrick O. Onono, Michael A. Morgan, PhD, Kristine A. Henningfeld, PhD, Arnold Ganser, MD/PhD
Journal: Blood
Blood (2006) 108 (11): 1439.
https://doi.org/10.1182/blood.V108.11.1439.1439
Published: 2006
Journal Articles

Prenylation Inhibitors Block IL-6 and IGF-1 Dependent Activation of RAS Signaling in Multiple Myeloma Cells.

Christoph W.M. Reuter, MD, PhD, Michael A. Morgan, PhD, Dietrich Peest, MD/PhD, Arnold Ganser, MD/PhD
Journal: Blood
Blood (2005) 106 (11): 3373.
https://doi.org/10.1182/blood.V106.11.3373.3373
Published: 2005
Journal Articles

Targeting RAS Signaling in Multiple Myeloma (MM): Synergistic Inhibition by Co-Treatment with the MEK Inhibitor U0126 and Prenylation Inhibitors.

Christoph W.M. Reuter, MD/Ph.D., Michael A. Morgan, Ph.D., Tarkan Sebil, Arnold Ganser, MD/Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3398.
https://doi.org/10.1182/blood.V104.11.3398.3398
Published: 2004